menu
    • menu

    Company profile for Mannin Research

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mannin Research is a biotechnology company focused on the discovery, development, and commercialization of first-in-class therapeutics for vascular diseases. Our lead indication is for treatment of Primary Open-Angle Glaucoma. Mannin Research is a research stage biotechnology company focused on the discovery, development, and commercialization of first-in-class therapeutics for vascular diseases using the Tie2 mechanism of act...
    Mannin Research is a biotechnology company focused on the discovery, development, and commercialization of first-in-class therapeutics for vascular diseases. Our lead indication is for treatment of Primary Open-Angle Glaucoma. Mannin Research is a research stage biotechnology company focused on the discovery, development, and commercialization of first-in-class therapeutics for vascular diseases using the Tie2 mechanism of action. Mannin’s Tie2 platform technology addresses a number of vascular disease indications. Mannin is currently developing a small molecule to reduce intra-ocular pressure.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mannin ResearchCanada Flag
    Country
    Country
    Canada
    Address
    Address
    629 Eastern Avenue, Suite C300 Toronto, Ontario M4M 1E4
    Telephone
    Telephone
    (416) 775 9767
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://mannin.ca/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/manninresearch
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/manninresearch?lang=bg

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Navigo and Mannin Sign Agreement to Develop Innovative Affinity Ligand Against
    Navigo and Mannin Sign Agreement to Develop Innovative Affinity Ligand Against

    26 Sep 2022

    // B3CNEWSWIRE

    https://www.b3cnewswire.com/202209262396/navigo-and-mannin-sign-agreement-to-develop-innovative-affinity-ligand-against-a-novel-drug-for-the-treatment-of-covid-19.html

    B3CNEWSWIRE
    26 Sep 2022
    Share Share
    Mannin Implements CDD Vault Informatics Platform
    Mannin Implements CDD Vault Informatics Platform

    23 Nov 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/mannin-gmbh-implements-cdd-vault-informatics-platform-to-facilitate-data-management-and-collaboration-301431027.html

    PRNEWSWIRE
    23 Nov 2021
    Share Share
    Q BioMed Partner Mannin Research Developing Potential Treatment for Coronavirus
    Q BioMed Partner Mannin Research Developing Potential Treatment for Coronavirus

    04 Feb 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/q-biomed-partner-mannin-research-developing-potential-treatment-for-patients-infected-with-coronavirus-and-other-infectious-diseases-300998059.html

    PR NEWSWIRE
    04 Feb 2020
    Share Share
    Mannin Presents +Ve Data for Treatment of Kidney Injury with Tie2 Activator
    Mannin Presents +Ve Data for Treatment of Kidney Injury with Tie2 Activator

    26 Nov 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/q-biomed-technology-partner-mannin-research-inc-presents-data-showing-potential-treatment-to-protect-the-kidney-in-acute-kidney-injury-using-mannin-tie2-activator-300964967.html

    PR NEWSWIRE
    26 Nov 2019
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search